Is Molagri profitable in 2026?

No. Molagri is a pre-revenue, 4-person YC Summer 2026 biotech startup based in Toronto. No revenue, customers, or pilot data have been disclosed as of July 2026, consistent with an early-stage company still developing its biopesticide technology.

Could AI replace Molagri's technology?

Partly. Molagri's own pitch relies on predictive modeling of pest resistance, but rival YC startup Red Barn Robotics (W25) already markets custom AI models for pesticide design, suggesting the discovery layer Molagri leads with could become commoditized by AI as of July 2026.

Molagri was founded in 2026 by University of Toronto PhD biochemists Zaky Hassan and Min Jin, described as lab mates for six years with prior publications in Nature Communications and Nature Microbiology, per YC and company profile pages.

Who is Molagri's biggest competitor?

Moa Technology (Oxford, UK) raised GBP 22.2 million in July 2026 for herbicide resistance discovery and licenses to major agrochemical firms; Red Barn Robotics (YC W25) is a direct AI-driven pesticide design rival.

Has Molagri raised any funding?

No priced funding round, valuation, or total capital raised has been publicly disclosed as of July 2026. Molagri is backed by Y Combinator's S26 batch; a third-party aggregator names an investor called 'JCJulian Capital,' unconfirmed by primary sources.

Will Bayer or Corteva acquire Molagri?

Unclear. Incumbents like Bayer, Corteva, and Syngenta typically license or acquire successful biopesticide platforms, as seen when Ginkgo Bioworks acquired AgBiome in April 2024, but Molagri has no field-trial or regulatory data yet as of July 2026.

YC Summer 2026 · Canada

Molagri

Toronto biotech designing resistance-free pesticides, pre-revenue, YC S26 batch.

Losing its protection

Assessed 27 July 2026 · Evidence as of 27 July 2026

The structural protection is eroding.

On the recordSince 27 July 2026 · Checkable from Q4 2026 · Every call on the record Checkpoint: YC S26 Demo Day and any first field-trial or regulatory filing disclosure

The call

Molagri has real chemistry talent but no field data, no filing, and no partner yet, in a space where AI-driven rivals and big buyers both move faster.

Molagri is a tiny startup (4 people, no sales yet) trying to discover and sell new pesticides made from nature instead of chemicals. The founders are smart scientists, and the farming industry is hungry for alternatives, so they can probably invent something real. However, they face two big problems: large chemical companies like Bayer and Corteva could buy or copy their work once it proves itself, and AI tools (like Red Barn Robotics, another startup using artificial intelligence to design pesticides) are getting so good at finding new compounds that the hard part of discovery may stop being rare. The one thing that changes everything is whether Molagri or a competitor gets real proof from actual farm tests and a deal with a major company first; whoever hits that milestone wins, and everyone else becomes less interesting.

Why

AI pressure: Red Barn Robotics (YC W25, custom AI models for pesticide design). AI-driven molecule design could commoditize the discovery step Molagri leads with, before Molagri reaches field trials. Could AI do the core job? Only partly.

Bigger players: Bayer, Corteva, Syngenta. These firms buy or license promising molecules rather than compete directly, so the real risk is being absorbed early or ignored. Could a giant copy it? Yes, easily.

What protects it. Founders hold published biochemistry work in Nature journals, giving them a real shot at a patentable molecule if trials confirm it works.

What would change this call

Molagri discloses field-trial or resistance-durability data within 12-18 months. Shows whether Molagri can convert lab science into validated real-world efficacy.
Moa Technology or Red Barn Robotics announces a licensing deal with Bayer, Corteva, or Syngenta. Would show a rival closing the moat gap first, narrowing Molagri's window.
Molagri's YC S26 Demo Day funding or Series A terms become public. Indicates investor confidence in Molagri despite lack of revenue or trial data.

Key numbers

4 employees as of July 2026 (2026-07-20)
AgBiome sold to Ginkgo Bioworks after raising $236.5M (2026-02-26)
Vestaron raised $18.3M Series B for peptide pesticides (2025-08-03)

Named risks

No field-trial or regulatory filing (EPA/EU) data disclosed as of July 2026. Severity: high
AI-driven rivals like Red Barn Robotics could commoditize the molecule discovery and resistance-prediction layer. Severity: high
No disclosed funding round or valuation, unclear runway for a 4-person team. Severity: medium
Regulatory and field-validation timeline (typically 4-7 years) exceeds typical venture equity horizons. Severity: high
Crowded emerging field with better-funded direct peers (Moa, Vestaron) racing same thesis. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Moa Technology	gaining on	Raised GBP 22.2M in July 2026, ahead in funding with a licensing-to-incumbents model
Red Barn Robotics	contesting	YC W25 firm building pesticides via custom AI models, directly contesting Molagri's discovery layer
AgBiome (Ginkgo Bioworks)	contesting	Acquired by Ginkgo Bioworks in April 2024 after raising $236.5M, showing consolidation pressure in biologicals
Vestaron	contesting	Established peptide-based pollinator-safe insecticide maker, funded since 2021 Series B of $18.3M
Bayer, Corteva, Syngenta	gaining on	Typical acquirers/licensees of successful biopesticide platforms rather than blockers, per July 2026 industry coverage

Questions people ask

Is Molagri profitable in 2026?: No. Molagri is a pre-revenue, 4-person YC Summer 2026 biotech startup based in Toronto. No revenue, customers, or pilot data have been disclosed as of July 2026, consistent with an early-stage company still developing its biopesticide technology.
Could AI replace Molagri's technology?: Partly. Molagri's own pitch relies on predictive modeling of pest resistance, but rival YC startup Red Barn Robotics (W25) already markets custom AI models for pesticide design, suggesting the discovery layer Molagri leads with could become commoditized by AI as of July 2026.
Who founded Molagri?: Molagri was founded in 2026 by University of Toronto PhD biochemists Zaky Hassan and Min Jin, described as lab mates for six years with prior publications in Nature Communications and Nature Microbiology, per YC and company profile pages.
Who is Molagri's biggest competitor?: Moa Technology (Oxford, UK) raised GBP 22.2 million in July 2026 for herbicide resistance discovery and licenses to major agrochemical firms; Red Barn Robotics (YC W25) is a direct AI-driven pesticide design rival.
Has Molagri raised any funding?: No priced funding round, valuation, or total capital raised has been publicly disclosed as of July 2026. Molagri is backed by Y Combinator's S26 batch; a third-party aggregator names an investor called 'JCJulian Capital,' unconfirmed by primary sources.
Will Bayer or Corteva acquire Molagri?: Unclear. Incumbents like Bayer, Corteva, and Syngenta typically license or acquire successful biopesticide platforms, as seen when Ginkgo Bioworks acquired AgBiome in April 2024, but Molagri has no field-trial or regulatory data yet as of July 2026.

Timeline

2026-07-24Moa Technology raises GBP 22.2M for herbicide resistance discovery, intensifying competitive field
2026-07-21Molagri profile describes founders Zaky Hassan and Min Jin, U of T PhD biochemists
2026-07-20YC directory lists Molagri with 4 employees, HQ Toronto, part of S26 batch
2026-04-17Industry blog covers biopesticide startup wave including AI rival Red Barn Robotics
2025-08-03AgFunderNews op-ed by Vestaron argues EU policy lags new biopesticide class
2024-04AgBiome, having raised $236.5M total, acquired by Ginkgo Bioworks
2021Vestaron raises $18.3M Series B for peptide-based pollinator-safe insecticides

Revision history

27 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Cosmic Robotics Pango Atlas Discovery